Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602.
about
mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization.Assessment of response to therapy in hepatocellular carcinomaSignificant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma: A care-compliant casePrognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapyWavelet-based algorithm to the evaluation of contrasted hepatocellular carcinoma in CT-images after transarterial chemoembolization.Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection.Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib.Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt.Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment.Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma.Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
P2860
Q30408237-1D91144B-110E-4E92-BB08-A3847C727C5AQ33560982-B960A464-4706-4AE3-9C40-560004773592Q33590673-E7ED07AB-D3FA-4896-923F-0D59F00A311EQ33727749-344539FD-FF83-43B4-A319-B9E4F9C40EF0Q33997613-8B23BDED-1AEA-444D-97D2-43F426270065Q34077181-92BCE980-A23F-44BC-A3C0-21528784A544Q35731141-F31EC5FB-C943-4C8B-B693-F26D663CD222Q36290421-1876D821-50BD-4A62-919A-B6D82DA16E26Q36356419-0128EC00-AA76-4136-8CA4-623842B06A8EQ37408313-7362A241-A863-4353-BA53-84E59FD042F8Q38164112-F6FCF8CE-9CBF-4EC1-A76E-0CA122EDC162Q38265024-632DE6A7-DB57-4A41-9CBA-43C28F62980CQ38638574-31CEDF35-7424-433E-A29C-80E7C32F1588Q42963762-AE700280-24EC-44A0-A4D6-84263FE451A1Q53173190-A0770EF2-4A7D-4475-8A26-F381FC99E872Q57494813-16FDCC33-FDF4-4B5F-9345-E3135986ABFF
P2860
Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tumor response evaluation crit ...... odified RECIST): JIVROSG-0602.
@ast
Tumor response evaluation crit ...... odified RECIST): JIVROSG-0602.
@en
type
label
Tumor response evaluation crit ...... odified RECIST): JIVROSG-0602.
@ast
Tumor response evaluation crit ...... odified RECIST): JIVROSG-0602.
@en
prefLabel
Tumor response evaluation crit ...... odified RECIST): JIVROSG-0602.
@ast
Tumor response evaluation crit ...... odified RECIST): JIVROSG-0602.
@en
P2093
P2860
P1476
Tumor response evaluation crit ...... odified RECIST): JIVROSG-0602.
@en
P2093
Hiroaki Onaya
Hirokazu Watanabe
Japan Interventional Radiology in Oncology Study Group-JIVROSG
Keigo Osuga
Masahide Takahashi
Miyuki Sone
Noriaki Sakamoto
Yasuaki Arai
P2860
P356
10.3109/03009734.2012.729104
P577
2012-11-20T00:00:00Z